Dermatologic extrahepatic manifestations of hepatitis C

Journal of Clinical and Translational Hepatology

Volumn 3, Issue 2, 2015, Pages 127-133

  Dedania, Bhavtosh ^a   Wu, George Y ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cryoglobulinemia; Dermatologic manifestations; Extra hepatic manifestations; Hepatitis C virus; Lichen planus; Porphyria cutanea tarda

Indexed keywords

EID: 85012245922     PISSN: 22250719     EISSN: 23108819     Source Type: Journal    
DOI: 10.14218/JCTH.2015.00010     Document Type: Review

References (47)

1. Saadoun D, Asselah T, Resche-Rigon M, Charlotte F, Bedossa P, Valla D, et al. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C. Hepatology 2006;43:1337–1345. doi: 10.1002/hep.21190.
2. Cacoub P, Gragnani L, Comarmond C, Zignego AL. Extrahepatic manifestations of chronic hepatitis C virus infection. Dig Liver Dis 2014;46(Suppl): S165–S173. doi: 10.1016/j.dld.2014.10.005.
3. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000;20:1–16.
4. Zignego AL, Giannini C, Monti M, Gragnani L. Hepatitis C virus lymphotrop-ism: lessons from a decade of studies. Dig Liver Dis 2007;39(Suppl), S38–S45. doi: 10.1016/S1590-8658(07)80009-0.
5. Ramos-Casals M, Font J. Extra hepatic manifestations in patients with chronic hepatitis C virus infection. Curr Opin Rheumatol 2005;17:447–455.
6. Younossi ZM, Stepanova M, Mishra A, Venkatesan C, Henry L, Hunt S. The impact of chronic hepatitis C on resource utilization and in-patient mortality for Medicare beneficiaries between 2005 and 2010. Aliment Pharmacol Ther 2013;38:1065–1075. doi: 10.1111/apt.12485.
7. Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet 2012;379:348–360. doi: 10.1016/S0140-6736(11)60242-0.
8. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and Clinical Significance of Cryoglobulins. A report of 86 cases. Am J Med 1974;57: 775–788.
9. Sène D, Limal N, Cacoub P. Hepatitis C Virus-Associated Extrahepatic Mani-festations: A Review. Metab Brain Dis 2004;19:357–381.
10. Güngör E, Cirit A, Alli N, Karakayali G, Gür G, Artüz F. Prevalence of Hepatitis C Virus Antibodies and Cryoglobulinemia in Patients with Leukocytoclastic Vasculitis. Dermatology 1999;198:26–28. doi: 10.1159/000018059.
11. Fallahi P, Ferri C, Ferrari SM. The Emerging Extra Hepatic Manifestations of Hepatitis C Virus Infection in Chronic Hepatitis and Mixed Cryoglobulinemia. Hepat Mon 2008;8:207–211.
12. Ko HM, Hernandez-Prera JC, Zhu H, Dikman SH, Sidhu HK, Ward SC, et al. Morphologic Features of Extrahepatic Manifestations of Hepatitis C Virus Infection. Clin Dev Immunol 2012;2012:740138. doi: 10.1155/2012/740138.
13. Stefanova-Petrova DV, Tzvetanska AH, Naumova EJ, Mihailova AP, Hadjiev EA, Dikova RP, et al. Chronic hepatitis C virus infection: Prevalence of extra hepatic manifestations and association with Cryoglobulinemia in Bulgarian patients. World J Gastroenterol 2007;13:6518–6528. doi: 10.3748/wjg.v13. i48.6518.
14. Hadziyannis SJ. The spectrum of extra hepatic manifestations in hepatitis C virus infection. J Viral Hepat 1997;4:9–28.
15. Terrier B, Semoun O, Saadoun D, Sène D, Resche-Rigon M, Cacoub P. Prog-nostic Factors in Patients with Hepatitis C Virus Infection and Systemic vas-culitis. Arthritis Rheum 2011;63:1748–1757. doi: 10.1002/art.30319.
16. Khattab MA, Eslam M, Alavian SM. Hepatitis C Virus as a Multifaceted Dis-ease: A Simple and Updated Approach for Extrahepatic Manifestations of Hepatitis C Virus Infection. Hepat Mon 2010;10:258–269.
17. Ramos-Casals M, Robles A, Brito-Zerón P, Nardi N, Nicolás JM, Forns X, et al. Life-threatening Cryoglobulinemia: Clinical and Immunological Characterization of 29 Cases. Semin Arthritis Rheum. 2006;36:189–196. doi: 10.1016/j. semarthrit.2006.08.005.
18. Paredes AH, Torres DM. Extra hepatic Manifestations of Hepatitis C Virus Infection: Mixed Cryoglobulinemia and Beyond. Curr Hepatol Rep 2011;10: 11–18. doi: 10.1007/s11901-010-0062-2.
19. Jadali Z. Dermatologic Manifestations of Hepatitis C Infection and the Effect of Interferon Therapy: A Literature Review: Zohreh Jadali. Dermatologic Manifestations of Hepatitis C Infection and the Effect of Interferon Therapy: A Literature Review. Arch Iran Med 2012;15:43–48. doi: 012151/AIM.0012.
20. Saadoun D, Resche Rigon M, Thibault V, Longuet M, Pol S, Blanc F, et al. PegIFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixedcryoglobulinemia vasculitis: results at week 24. Ann Rheum Dis 2014;73: 831–837. doi: 10.1136/annrheumdis-2012-202770.
21. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, et al. Interferon Alfa-2a Therapy in Cryoglobulinemia Associated with Hepatitis C Virus. N Engl J Med 1994;330:751–756. doi: 10.1056/NEJM199403173301104.
22. Nishida N, Kudo M. Clinical Features of Vascular Disorders Associated with Chronic Hepatitis Virus Infection. Dig Dis 2014;32:786–790. doi: 10. 1159/000368023.
23. Chuang TY, Brashear R, Lewis C. Porphyria cutanea tarda and hepatitis C virus: A case-control study and meta-analysis of the literature. J Am Acad Dermatol 1999;41:31–36. doi: 10.1016/S0190-9622(99)70402-0.
24. Gisbert JP, García-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. J Hepatol 2003;39:620–627. doi: 10.1016/S0168-8278 (03)00346-5.
25. Bonkovsky HL, Mehta S. Hepatitis C: A review and update. J Am Acad Dermatol 2001;44:159–182.
26. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, et al. Porphyria Cutanea Tarda, Hepatitis C, and HFE Gene Muta-tions in North America. Hepatology 1998;27:1661–1669. doi: 10.1002/hep. 510270627.
27. Remoroza R, Wu GY. Extra hepatic manifestations of chronic hepatitis C. Chin J Dig Dis 2003;4:93–99. doi: 10.1046/j.1443-9573.2003.00131.x.
28. Ryan Caballes F, Sendi H, Bonkovsky HL. Hepatitis C, porphyria Cutanea Tarda and liver iron: an update. Liver Int 2012;32:880–893. doi: 10. 1111/j.1478-3231.2012.02794.x.
29. Tsukazaki N, Watanabe M, Irifune H. Porphyria Cutanea Tarda and hepatitis C virus infection. Br J Dermatol 1998;138:1015–1017. doi: 10.1046/j.1365-2133.1998.02269.x.
30. Eisen D, Carrozzo M, Bagan Sebastian JV, Thongprasom K. Number V Oral lichen planus: clinical features and management. Oral Dis 2005;11:338– 349. doi: 10.1111/j.1601-0825.2005.01142.x.
31. Farhi D, Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol 2010;28: 100–108. doi: 10.1016/j.clindermatol.2009.03.004.
32. Mayo MJ. Extra hepatic Manifestations of Hepatitis C Infection. Am J Med Sci 2003;325:135–148.
33. Petti S, Rabiei M, De Luca M, Scully C. The magnitude of the association between hepatitis C virus infection and oral lichen planus: meta-analysis and case control study. Odontology 2011;99:168–178. doi: 10. 1007/s10266-011-0008-3.
34. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of Extra-hepatic manifestations. Ann Intern Med 1995;123:615–620. doi: 10. 7326/0003-4819-123-8-199510150-00008.
35. Mokni M, Rybojad M, Puppin D Jr, Catala S, Venezia F, Djian R, et al. Lichen planus and hepatitis C virus. J Am Acad Dermatol 1991;24:792.
36. Lodi G, Pellicano R, Carrozzo M. Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis. Oral Dis 2010;16:601–612. doi: 10. 1111/j.1601-0825.2010.01670.x.
37. Bigby M. The Relationship between Lichen Planus and Hepatitis C Clarified. Arch Dermatol 2009;145:1048–1050. doi: 10.1001/archderm.145.9.1048.
38. Al-Nasser L, El-Metwally A. Oral lichen planus in Arab countries: a Review. J Oral Pathol Med 2014;43:723–727. doi: 10.1111/jop.12136.
39. Carrozzo M. Oral diseases associated with hepatitis C virus infection Part 2. Lichen planus and other diseases. Oral Dis 2008;14:217–228. doi: 10. 1111/j.1601-0825.2007.01432.x.
40. Mignogna MD, Fedele S, Lo Russo L, Ruoppo E, Adamo D, Lo Muzio L. Extra hepatic manifestations of Hepatitis C virus infection: the slowly unraveling picture of oral lichen planus. J Hepatol 2002;37:412–413. doi: 10. 1016/S0168-8278(02)00173-3.
41. Grote M, Reichart PA, Berg T, Hopf U. Hepatitis C virus (HCV)-infection and oral lichen planus. J Hepatol 1998;29:1034–1035. doi: 10.1016/S0168-8278(98)80139-6.
42. Kumar KPM, Jois HS, Hallikerimath S, Kale AD. Oral Lichen Planus as an Extra–hepatic Manifestation of Viral Hepatitis–Evaluation in Indian Subpopu-lation. J Clin Diagn Res 2013;7:2068–2069. doi: 10.7860/JCDR/2013/5731. 3407.
43. Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(Suppl):S25.e1–e12. doi: 10.1016/j.tripleo.2006. 11.001.
44. Terrier B, Jehan F, Munteanu M, Geri G, Saadoun D, Sène D, et al. Low 25-hydroxyvitamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infection. Rheumatology (Oxford) 2012;51:2083–2090. doi: 10.1093/rheumatology/kes209.
45. Lauletta G. HCV, Mixed Cryoglobulinemia and Malignant Lymphoprolifera-tion. In: Serviddio G, ed. Practical Management of Chronic Viral Hepatitis. InTech: 2013. doi: 10.5772/55474.
46. Ferri C. Mixed Cryoglobulinemia. Orphanet J Rare Dis 2008;3:25. doi: 10. 1186/1750-1172-3-25.
47. Zakko L, Finch J, Rothe MJ, Grant-Kels JM. Hepatitis C Virus: Dermatological features. In: Grant-Kels JM, Selsky N, Wu GY, eds. Atlas of Dermatological Manifestations of Gastrointestinal Disease. Springer: 2013,167–169. doi: 10.1007/978-1-4614-6191-3_64.